UC Davis Medical Group - Sacramento (J Street)
2825 J St., Suite 400
Sacramento, CA 95816
Additional Phone Numbers
Dr. Oldham is a pulmonologist with expertise in Interstitial Lung Disease (ILD), including idiopathic pulmonary fibrosis, hypersensitivity pneumonitis, and connective tissue disease-related interstitial lung disease. He serves as director of the ILD clinical and research program at UC-Davis and oversees the ILD patient registry and biorepository.
Dr. Oldham's research interests lie in early ILD detection and translating biomarker research into clinical application.
Pulmonary, Critical Care, and Sleep Medicine
UC Davis Medical Group, Sacramento - J Street
M.D., University of Colorado School of Medicine, Denver CO 2006
M.S., Biostatistics and Epidemiology, University of Chicago, Chicago IL 2015
B.A., University of Colorado, Boulder CO 2002
Internship: Internal Medicine, UC Davis Medical Center, Sacramento CA 2006-2007
Internal Medicine, UC Davis Medical Center, Sacramento CA 2007-2009
Pulmonary and Critical Care, University of Chicago, Chicago IL 2011-2016
American Board of Internal Medicine,
American Board of Internal Medicine, Critical Care Medicine, 2014
American Board of Internal Medicine, Pulmonary and Critical Care Medicine,
American Board of Internal Medicine, Pulmonary Medicine, 2013
American College of Chest Physicians
American Thoracic Society
European Respiratory Society
Honors and Awards
Intl Colloquium on Lung and Airway Fibrosis Scientific Merit Award, 2018
American College of Chest Physicians Pulmonary Fibrosis Award, 2018
Philip Thai Memorial Lung Research Award, 2016
Pulmonary Fibrosis Foundation Summit Poster Award, 2015
American Thoracic Society Clinical Problems Abstract Award, 2015
Janet Rowley Research Day Clinical Abstract Award, 2014
Medical Student Teaching Award, 2010
Select Recent Publications
Adegunsoye A, Oldham JM, Bellam SK, Chung JH, Chung PA, Biblowitz KM, Montner S, Lee C, Hsu S, Husain AN, Vij R, Mutlu G, Noth I, Churpek MM, Strek ME. African-American race and mortality in interstitial lung disease: a multicentre propensity-matched analysis. The European respiratory journal. 2018;(51).
Adegunsoye A, Oldham JM, Bonham C, Hrusch C, Nolan P, Klejch W, Bellam S, Mehta U, Thakrar K, Pugashetti JV, Husain AN, Montner SM, Straus CM, Vij R, Sperling AI, Noth I, Strek ME, Chung JH. Prognosticating Outcomes in Interstitial Lung Disease by Mediastinal Lymph Node Assessment: An Observational Cohort Study with Independent Validation. American journal of respiratory and critical care medicine 2018.
Pugashetti J, Graham J, Boctor N, Mendez C, Foster E, Juarez M, Harper R, Morrissey B, Kadoch M, Oldham JM. Weight loss as a predictor of mortality in patients with interstitial lung disease. The European respiratory journal. 2018;(52).
Oldham JM, Adegunsoye A, Khera S, Lafond E, Noth I, Strek ME, Kadoch M, Chung JH. Underreporting of Interstitial Lung Abnormalities on Lung Cancer Screening Computed Tomography. Ann Am Thorac Soc. 2018;(15): 764-766.
Adegunsoye A, Oldham JM, Chung JH, Montner SM, Lee C, Witt LJ, Stahlbaum D, Bermea RS, Chen LW, Hsu S, Husain AN, Noth I, Vij R, Strek ME, Churpek M. Phenotypic Clusters Predict Outcomes in a Longitudinal Interstitial Lung Disease Cohort. Chest. 2017.
Oldham JM, Adegunsoye A, Valenzi E, Lee C, Witt L, Chen L, Husain AN, Montner S, Chung JH, Cottin V, Fischer A, Noth I, Vij R, Strek ME. Characterization of patients with interstitial pneumonia with autoimmune features. European Respiratory Journal. 2016.
Adegunsoye A, Oldham JM, Demchuk C, Montner S, Chung JH, Vij R, Strek ME. Predictors of survival in coexistent hypersensitivity pneumonitis with autoimmune features. Respiratory Medicine. 2016.
Oldham JM, Ma SF, Martinez FJ, Anstrom KJ, Raghu G, Schwartz DA, Valenzi E, Witt L, Lee C, Vij R, Huang Y, Strek ME, Noth I; IPFnet Investigators. TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2015 Dec 15;192(12):1475-82.
Oldham JM, Kumar D, Lee C, Patel SB, Takahashi-Manns S, Demchuk C, Strek ME, Noth I. Thyroid Disease Is Prevalent and Predicts Survival in Patients With Idiopathic Pulmonary Fibrosis. Chest. 2015 Sep;148(3):692-700.
Huang Y, Ma SF, Vij R, Oldham JM, Herazo-Maya J, Broderick SM, Strek ME, White SR, Hogarth DK, Sandbo NK, Lussier YA, Gibson KF, Kaminski N, Garcia JG, Noth I. A functional genomic model for predicting prognosis in idiopathic pulmonary fibrosis. BMC Pulm Med. 2015 Nov 21;15:147.